SLC3A2 is a novel endoplasmic reticulum stress-related signaling protein that regulates the unfolded protein response and apoptosis

PLoS One. 2018 Dec 28;13(12):e0208993. doi: 10.1371/journal.pone.0208993. eCollection 2018.

Abstract

Endoplasmic reticulum (ER) stress results from imbalances in unfolded/misfolded proteins, contributing to a wide variety of human diseases. To better understand the mechanisms involved in the cellular response to ER stress in cardiomyocytes, we previously conducted a genome-wide screening in an in vitro ER stress model of rat cardiomyocytes, which highlighted amino acid transporter heavy chain, member 2 (SLC3A2) as an important factor in ER stress. In the present study, we characterized the role of SLC3A2 during the unfolded protein response (UPR), as one of the primary pathways activated during ER stress. First, we confirmed the induction of Slc3a2 mRNA expression following treatment with various ER stress inducers in rat cardiomyocytes (H9C2) and neural cells (PC12). Knockdown of Slc3a2 expression with small interfering RNA (siRNA) revealed that the encoded protein functions upstream of three important UPR proteins: ATF4, ATF6, and XBP1. siRNA-mediated knockdown of both SLC3A2 and mammalian target of rapamycin 1 (mTOR1) revealed that mTOR1 acts as a mediator between SLC3A2 and the UPR. RNA sequencing was then performed to gain a more thorough understanding of the function of SLC3A2, which identified 23 highly differentially regulated genes between the control and knockdown cell lines, which were related to the UPR and amino acid transport. Notably, flow cytometry further showed that SLC3A2 inhibition also enhanced the apoptosis of rat cardiomyocytes. Taken together, these results highlight SLC3A2 as a complex, multifunctional signaling protein that acts upstream of well-known UPR proteins with anti-apoptotic properties, suggesting its potential as a therapeutic target for ER stress-related diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 4 / antagonists & inhibitors
  • Activating Transcription Factor 4 / genetics
  • Activating Transcription Factor 4 / metabolism
  • Animals
  • Apoptosis* / drug effects
  • Cell Line
  • Down-Regulation
  • Endoplasmic Reticulum Stress* / drug effects
  • Fusion Regulatory Protein 1, Heavy Chain / antagonists & inhibitors
  • Fusion Regulatory Protein 1, Heavy Chain / genetics
  • Fusion Regulatory Protein 1, Heavy Chain / metabolism*
  • Heat-Shock Proteins / genetics
  • Heat-Shock Proteins / metabolism
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / metabolism
  • PC12 Cells
  • RNA Interference
  • RNA, Small Interfering / metabolism
  • Rats
  • TOR Serine-Threonine Kinases / metabolism
  • Thapsigargin / pharmacology
  • Unfolded Protein Response* / drug effects
  • X-Box Binding Protein 1 / antagonists & inhibitors
  • X-Box Binding Protein 1 / genetics
  • X-Box Binding Protein 1 / metabolism

Substances

  • Atf4 protein, rat
  • Fusion Regulatory Protein 1, Heavy Chain
  • GRP78 protein, rat
  • Heat-Shock Proteins
  • RNA, Small Interfering
  • X-Box Binding Protein 1
  • Xbp1 protein, rat
  • Activating Transcription Factor 4
  • Thapsigargin
  • TOR Serine-Threonine Kinases

Grants and funding

This study was supported by Chinese PLA General Hospital Medical Large Data Project (No. 2016MBD-002), Chinese PLA General Hospital Translational Medicine Project (No. 2016-TM-013), Major International Science and Technology Cooperation Projects (No. 2013DFA31170) and National Key Technologies R&D Program for New Drug of China (2018ZX09J18109-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.